Yijia Group Corp. Files 8-K for Other Events

TL;DR

YIJIA filed an 8-K for 'Other Events' on Oct 7, 2025. Details TBD.

AI Summary

Yijia Group Corp. filed an 8-K on October 7, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself. The company is incorporated in Nevada and its principal office is located in New York.

Why It Matters

This 8-K filing indicates that Yijia Group Corp. has reported significant events that are not covered by other standard 8-K items, requiring immediate disclosure to investors.

Risk Assessment

Risk Level: medium — The filing is for 'Other Events' without specific details, creating uncertainty about the nature and impact of these events.

Key Players & Entities

• YIJIA GROUP CORP. (company) — Registrant
• October 7, 2025 (date) — Date of Report
• Nevada (jurisdiction) — State of Incorporation
• 39 E Broadway , Suite 603 , New York , NY 10002 (address) — Principal Office Address
• 333-218733 (document_id) — Commission File Number
• 35-2583762 (identifier) — IRS Employer Identification No.

FAQ

Key Financial Figures

• $0.0001 — d 10,000,000 shares of preferred stock, $0.0001 par value per share (the " Share Capita

Filing Documents

• yijia_8k.htm (8-K) — 28KB
• 0001683168-25-007445.txt ( ) — 185KB
• yjgj-20251007.xsd (EX-101.SCH) — 3KB
• yjgj-20251007_lab.xml (EX-101.LAB) — 33KB
• yjgj-20251007_pre.xml (EX-101.PRE) — 22KB
• yijia_8k_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events. Yijia Group Corp. (the " Company ") has proposed to change the name of the Company to VitaNova Life Sciences Corporation (the " Name Change "). The Name Change was approved by the Board of Directors of the Company (the " Board ") and a majority of the holders of all of the issued and outstanding shares of common stock (" Common Stock ") of the Company. In connection with the Name Change, the Company intends to change its ticker symbol with OTC Markets Group Inc. Until the new ticker symbol becomes effective, the Company's Common Stock will continue to trade under its current ticker symbol and CUSIP number. The Company has also proposed to effect a reverse stock split at a ratio within the range from 1-for-2 to 1-for-3, such that each holder of Common Stock of the Company shall receive one (1) share of Common Stock for every two (2) or three (3) shares of Common Stock (the " Reverse Split "). The Reverse Split was approved by the Board and a majority of the holders of all of the issued and outstanding shares of Common Stock. Additionally, the Company has proposed to increase its authorized capital to 85,000,000 shares of capital stock, consisting of 75,000,000 shares of Common Stock and 10,000,000 shares of preferred stock, $0.0001 par value per share (the " Share Capital Increase "), and authorized the creation of blank check preferred stock, with such series, designations, rights and preferences as may be established from time to time by the Board (the " Preferred Stock Designation "). The Share Capital Increase and Preferred Stock Designation were approved by the Board the a majority of the holders of all of the issued and outstanding shares of Common Stock. The Company is currently evaluating and finalizing the ratio for the proposed reverse stock split. Following the determination of the reverse split ratio, the Company intends to file a Certificate of Amendment to its Articles of Incorporation with the Nevada Secretary of State to

View Full Filing

View this 8-K filing on SEC EDGAR